Abstract
Peter Nowell is known for his discovery that a small terminal deletion on chromosome 22 is a consistent feature in leukemic cells from chronic myelogenous leukemia (CML) patients. This was the first direct evidence that a human cancer could be the result of a somatic (chromosomal) mutation, and paved the way for the development of a therapy that now cures 95% of individuals with CML.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
